EnGeneIC: Potential new Covid-19 vax for mutant strains to be developed in Australia

An Australian biotech tech company is the first in the world to develop a potential nanocellular Covid-19 vaccine that’s expected to be more efficient against mutant strains and better suited for patients with compromised immune systems.

The unique drug developed by Sydney-based company…